Publications
WHY NALOXONE?
Naloxone is an easy-to-use, lifesaving antidote to overdose from heroin or other opioids. Used in hospitals for decades, the medication has no abuse potential, costs as little as one dollar for a lifesaving dose and can be administered with basic training.
Naloxone is an easy-to-use, lifesaving antidote to overdose from heroin or other opioids. Used in hospitals for decades, the medication has no abuse potential, costs as little as one dollar for a lifesaving dose and can be administered with basic training.
International Overdose Awareness Day
Committed to providing a platform to acknowledge the grief felt by families and friends who have lost a loved one to overdose. We aim to raise awareness that the tragedy of overdose death is preventable.
Committed to providing a platform to acknowledge the grief felt by families and friends who have lost a loved one to overdose. We aim to raise awareness that the tragedy of overdose death is preventable.
ASEAN and HIV prevention amongst people who inject drugs: the need for an e ective and sustainable response
Between 2010 and 2016, Asia and the Paci c registered one of the steepest declines in HIV infec ons globally, with prevalence rates dropping by approximately 13%. Despite this overall reduc on, HIV prevalence among people who inject drugs in Southeast Asia remains among the world’s highest.
Between 2010 and 2016, Asia and the Paci c registered one of the steepest declines in HIV infec ons globally, with prevalence rates dropping by approximately 13%. Despite this overall reduc on, HIV prevalence among people who inject drugs in Southeast Asia remains among the world’s highest.
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries
Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction services such as opioid substitution therapy (OST) and needle and syringe programs (NSPs) are effective in preventing the further spread of HCV and HIV, the extent to which these are available in prisons varies significantly across countries.
Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction services such as opioid substitution therapy (OST) and needle and syringe programs (NSPs) are effective in preventing the further spread of HCV and HIV, the extent to which these are available in prisons varies significantly across countries.
The Global Fund Eligibility Policy and its impact on harm reduction funding
The Global Fund to Fight AIDS, TB and Malaria is the largest funder of harm reduction globally, but its eligibility policy currently precludes certain Upper Middle Income Countries (UMICs) from applying for funding.
The Global Fund to Fight AIDS, TB and Malaria is the largest funder of harm reduction globally, but its eligibility policy currently precludes certain Upper Middle Income Countries (UMICs) from applying for funding.
Why access to morphine is a human right
"It’s easy to think of human rights as in some way innate, as something we and our ancestors have all simply been born with." says Jonathan Leighton, Executive Director, Organisation for the Prevention of Intense Suffering (OPIS)
"It’s easy to think of human rights as in some way innate, as something we and our ancestors have all simply been born with." says Jonathan Leighton, Executive Director, Organisation for the Prevention of Intense Suffering (OPIS)
Harm Reduction: More than just clean needles
Harm reduction is a realistic, pragmatic and non-judgmental approach based upon openness, understanding and respect.
Harm reduction is a realistic, pragmatic and non-judgmental approach based upon openness, understanding and respect.
Drug-related deaths in Scotland 1979–2013: evidence of a vulnerable cohort of young men living in deprived areas
Even after accounting for deprivation, mortality rates are higher in Scotland relative to the rest of Western Europe. Higher mortality from alcohol- and drug-related deaths (DRDs), violence and suicide (particularly in young adults) contribute to this ‘excess’ mortality.
Even after accounting for deprivation, mortality rates are higher in Scotland relative to the rest of Western Europe. Higher mortality from alcohol- and drug-related deaths (DRDs), violence and suicide (particularly in young adults) contribute to this ‘excess’ mortality.
TAKING A NEW LINE ON DRUGS
‘Taking a New Line on Drugs’ assesses the situation in the UK as regards rising health harm from illegal drugs, with reference to their context within the wider ‘drugscape’ of legal drugs such as alcohol and tobacco, and sets out a new vision for a holistic public health-led approach to drugs policy at a UK-wide level.
‘Taking a New Line on Drugs’ assesses the situation in the UK as regards rising health harm from illegal drugs, with reference to their context within the wider ‘drugscape’ of legal drugs such as alcohol and tobacco, and sets out a new vision for a holistic public health-led approach to drugs policy at a UK-wide level.
UN Human Rights Council reaffirms role of human rights in international drug policy debate
Last Friday evening, 23 March 2018, the United Nations (UN) Human Rights Council concluded its 3-week long session by voting to adopt a Resolution reaffirming that human rights must play a central role in the ongoing international debate on global drug policies.
Last Friday evening, 23 March 2018, the United Nations (UN) Human Rights Council concluded its 3-week long session by voting to adopt a Resolution reaffirming that human rights must play a central role in the ongoing international debate on global drug policies.
